Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T20:09:06.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown on the page. The previous revision label v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:24:36.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.
    Difference
    0.4%
    Check dated 2026-02-11T01:40:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A system-wide notice about a lapse in government funding was added and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T22:17:53.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Adds a glossary toggle and a new QC label 'Last Update Submitted that Met QC Criteria', and updates FEAR Act text plus version to v3.4.0 while removing the older QC label and older FEAR Act wording. These are UI/metadata updates and do not change the core study content.
    Difference
    0.2%
    Check dated 2026-01-27T17:28:49.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T15:40:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.